After five years of clinical research, a new dengue vaccine may soon become available throughout Europe.
The European Medicines Agency (EMA) human medicines committee adopted a positive opinion for QDENGA® (TAK-003) Dengue Tetravalent Vaccine (live, attenuated) on October 14, 2022.
Read More
